Rajnish Wellness

What does Rajnish Wellness do?

Rajnish Wellness Ltd is a micro-cap company in the Pharmaceuticals & Biotechnology industry, selling consumer durables and ayurvedic personal care products. It was incorporated in 2015, became a public company in 2018, and reported net sales of 6 Cr and no profit for the quarter ending March 2025.

Overview: <BR>Rajnish Wellness Ltd is engaged in selling a variety of products, including consumer durables and ayurvedic personal care products, and operates within the Pharmaceuticals & Biotechnology industry in the micro-cap market.<BR><BR>History: <BR>Rajnish Wellness Ltd was originally incorporated on June 13, 2015, as a Private Limited Company under the name "Rajnish Hot Deals Private Limited." It was converted into a Public Limited Company on February 01, 2018, and subsequently renamed to "Rajnish Wellness Limited" on February 09, 2018. The latest quarterly results reported net sales and profit for the period ending March 2025.<BR><BR>Financial Snapshot: <BR>Net Sales: 6 Cr (Quarterly Results - Mar 2025) <BR>Net Profit: 0 Cr (Quarterly Results - Mar 2025) <BR>Market Cap: Rs 115 Cr (Micro Cap) <BR><BR>Key Metrics: <BR>P/E: 115.00 <BR>Industry P/E: 54 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.00 <BR>Return on Equity: 0.07% <BR>Price to Book: 1.37 <BR><BR>Contact Details: <BR>Address: Bldg No 3 Navijivan Comm Socie, 6 Th Floor Office No 10L Mumbai Maharashtra : 400008 <BR>Tel: 91-22-23065555 <BR>Email: info@rajnishwellness.com <BR>Website: http://www.rajnishwellness.com

What is the bonus history of the Rajnish Wellness?

Rajnish Wellness has a recent bonus history that includes a 2:1 bonus announced on July 21, 2022, and a 5:4 bonus issued on December 23, 2021, reflecting the company's commitment to rewarding shareholders.

Rajnish Wellness has a notable bonus history. The most recent bonus issue was a 2:1 bonus, which was announced with an ex-date of July 21, 2022, and a record date of July 22, 2022. Prior to that, the company issued a 5:4 bonus with an ex-date of December 23, 2021, and a record date of December 24, 2021. This indicates that Rajnish Wellness has been active in rewarding its shareholders through bonus issues in the recent past.

Has Rajnish Wellness declared dividend?

No Dividend History Available

What is the technical trend for Rajnish Wellness?

As of June 6, 2025, Rajnish Wellness shows a bearish trend with weak strength, supported by bearish monthly indicators and daily moving averages, despite some mixed signals from the MACD and RSI.

As of 6 June 2025, the technical trend for Rajnish Wellness has changed from mildly bearish to bearish. The current stance is bearish with weak strength. The weekly MACD is mildly bullish, but the monthly MACD and KST are bearish, indicating a lack of strong upward momentum. The RSI shows no signal on the weekly chart while being bullish on the monthly, suggesting mixed signals. Both the weekly and monthly Bollinger Bands are bearish, reinforcing the downward trend. Daily moving averages are bearish, further supporting the negative outlook. Overall, the indicators suggest a prevailing bearish sentiment in the short to medium term.

Who are the peers of the Rajnish Wellness?

Peers of Rajnish Wellness include Denis Chem Lab, Amwill Health, Parnax Lab, and others. Rajnish Wellness has below-average management risk and capital structure, with a 1-year return of -79.46%, the lowest among its peers.

Peers: The peers of Rajnish Wellness are Denis Chem Lab, Amwill Health, Parnax Lab, Samrat Pharma, Mercury Labs, Bharat Immunolog, Source Natural, Zenith Drugs, Vaishali Pharma, and Ajooni Biotech.<BR><BR>Quality Snapshot: Excellent management risk is observed at Amwill Health and Source Natural, while Good management risk is found at Samrat Pharma and Zenith Drugs. Average management risk is present at Denis Chem Lab, Rajnish Wellness, and Mercury Labs, while Below Average management risk is noted at Parnax Lab, Bharat Immunolog, Vaishali Pharma, and Ajooni Biotech. Growth is Excellent at Rajnish Wellness, Good at Amwill Health and Parnax Lab, while Below Average growth is seen at Denis Chem Lab, Mercury Labs, Bharat Immunolog, Source Natural, Zenith Drugs, and Vaishali Pharma, with the rest having Below Average growth. Capital Structure is Excellent at Amwill Health, Parnax Lab, Samrat Pharma, and Mercury Labs, while Rajnish Wellness has Below Average capital structure, and the rest have Below Average or Average capital structures.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Parnax Lab at 9.25%, while the peer with the lowest is Rajnish Wellness at -79.46%. Rajnish Wellness's 1-year return is significantly lower than all peers. Additionally, the following peers have negative six-month returns: Denis Chem Lab, Rajnish Wellness, Mercury Labs, Bharat Immunolog, Source Natural, and Vaishali Pharma.

Who are in the management team of Rajnish Wellness?

As of March 2020, the management team of Rajnish Wellness includes Rajnishkumar Surendra Prasad Singh (Managing Director), Shalini Vijendra Mishra (Whole-time Director and Non-Executive Director), several independent directors, and company secretaries, totaling 11 members. This diverse team oversees the company's governance and management.

As of March 2020, the management team of Rajnish Wellness includes the following members:<BR><BR>1. Rajnishkumar Surendra Prasad Singh - Managing Director<BR>2. Shalini Vijendra Mishra - Whole-time Director<BR>3. Shalini Vijendra Mishra - Non Executive Director<BR>4. Abhinandan Ashok Kumar Paliwal - Independent Director<BR>5. Madhukar Devappa Imade - Independent Director<BR>6. Heet Ashok Shah - Company Secretary<BR>7. Sanjjari Kashyap - Additional Director<BR>8. Rajveer Singh - Company Secretary<BR>9. Monam Kapoor - Independent Director<BR>10. Swati Jain - Additional Director<BR>11. Saloni Mehra - Additional Director<BR><BR>This team comprises a mix of directors and company secretaries, contributing to the governance and management of the company.

Who are the top shareholders of the Rajnish Wellness?

The top shareholders of Rajnish Wellness include promoter Rajnish Kumar Singh with 7.41%, individual investors holding 82.53%, and Skybridge Incap Advisory LLP as the largest public shareholder at 1.37%. The majority of shares are held by non-institutional investors, with no mutual fund holdings.

The top shareholders of Rajnish Wellness include Rajnish Kumar Singh, who is the promoter with the highest holding at 7.41%. The company also has a significant portion of individual investors holding 82.53% of the shares. Additionally, Skybridge Incap Advisory LLP is the highest public shareholder, holding 1.37%. There is one foreign institutional investor (FII) that holds 0.57% of the shares, while mutual funds do not hold any shares in the company. Overall, the majority of the shareholding is with non-institutional investors.

How big is Rajnish Wellness?

As of 24th July, Rajnish Wellness Ltd has a market capitalization of 118.00 Cr, with recent net sales of 48.55 Cr and a net profit of 0.06 Cr. The balance sheet for March 2024 shows shareholder's funds of 83.99 Cr and total assets of 106.26 Cr.

As of 24th July, Rajnish Wellness Ltd has a market capitalization of 118.00 Cr, categorized as a Micro Cap.<BR><BR>In the latest four quarters, the company reported Net Sales of 48.55 Cr and a Net Profit of 0.06 Cr.<BR><BR>The latest annual period for the balance sheet is March 2024, showing Shareholder's Funds of 83.99 Cr and Total Assets of 106.26 Cr.

How has been the historical performance of Rajnish Wellness?

Rajnish Wellness has experienced significant financial fluctuations, with net sales dropping from INR 76.68 crore in March 2024 to INR 48.56 crore in March 2025, alongside declines in profits and negative cash flow. Overall, the company is facing a challenging period marked by decreasing revenues and profits.

Answer:<BR>The historical performance of Rajnish Wellness shows significant fluctuations in its financial metrics over the years.<BR><BR>Breakdown:<BR>Rajnish Wellness experienced a decline in net sales from INR 76.68 crore in March 2024 to INR 48.56 crore in March 2025, following a notable increase from INR 25.03 crore in March 2023. The total operating income mirrored this trend, dropping to INR 48.56 crore in March 2025 from INR 76.68 crore in the previous year. The company reported no raw material costs, and the purchase of finished goods decreased to INR 46.33 crore in March 2025 from INR 76.54 crore in March 2024. Operating profit (PBDIT) fell to INR 0.52 crore in March 2025, down from INR 1.97 crore in March 2024, while profit before tax also decreased to INR 0.23 crore from INR 1.45 crore. Consequently, profit after tax dropped to INR 0.17 crore in March 2025 from INR 1.03 crore in the previous year. The company's total assets decreased to INR 91.28 crore in March 2025 from INR 106.26 crore in March 2024, and total liabilities also fell to INR 91.28 crore from INR 106.26 crore. Cash flow from operating activities was negative at INR -4.00 crore in March 2025, contrasting with a positive cash flow of INR 1.00 crore in March 2024. Overall, the financial performance of Rajnish Wellness reflects a challenging period with declining revenues and profits.

Is Rajnish Wellness overvalued or undervalued?

As of November 17, 2025, Rajnish Wellness is considered overvalued and risky, with a PE ratio of -738.43 and a year-to-date return of -44.06%, significantly underperforming compared to peers like Hindustan Unilever and Nestle India.

As of 17 November 2025, the valuation grade for Rajnish Wellness has moved from expensive to risky, indicating a significant deterioration in its perceived value. The company is currently assessed as overvalued. Key ratios highlight this concern, with a PE ratio of -738.43, an EV to EBITDA of -81.01, and a ROE of -0.13%. <BR><BR>When compared to peers, Rajnish Wellness stands out negatively against companies such as Hindustan Unilever, which has a PE ratio of 53.89, and Nestle India with a PE of 81.88. The stark contrast in valuation metrics underscores the challenges Rajnish Wellness faces in the market. Additionally, the company's stock has underperformed significantly, with a year-to-date return of -44.06% compared to the Sensex's positive return of 8.72%, reinforcing the notion of overvaluation in the current context.

When is the next results date for Rajnish Wellness Ltd?

The next results date for Rajnish Wellness Ltd is 07 February 2026.

The next results date for Rajnish Wellness Ltd is scheduled for 07 February 2026.

Are Rajnish Wellness Ltd latest results good or bad?

Rajnish Wellness Ltd's latest results are concerning, showing a net loss of ₹0.91 crores despite a 93.67% revenue increase, and a Mojo score of 12 out of 100 indicates a "Strong Sell" advisory. Overall, the company's financial health is troubling, marked by a 57.02% decline in stock value over the past year.

The latest results for Rajnish Wellness Ltd are concerning. The company reported a net loss of ₹0.91 crores for Q3 FY26, a significant decline from a profit of ₹0.06 crores in the previous quarter. While revenue saw a substantial increase of 93.67% quarter-on-quarter, rising to ₹23.24 crores, this growth has not translated into profitability, as the operating margin fell to -5.90%.<BR><BR>Overall, the company's financial health is troubling, with a Mojo score of just 12 out of 100, indicating a "Strong Sell" advisory. The stock has also experienced a steep decline of 57.02% over the past year, underperforming significantly compared to the broader market. With these factors in mind, the results can be characterized as bad, reflecting ongoing operational challenges and a lack of sustainable profitability.

Should I buy, sell or hold Rajnish Wellness Ltd?

Why is Rajnish Wellness Ltd falling/rising?

As of 10-Apr, Rajnish Wellness Ltd's stock price is rising to 0.54, reflecting a 3.85% increase. Despite recent short-term gains and outperforming benchmarks, the company faces long-term challenges, including operating losses and a negative EBITDA, which may affect future performance.

As of 10-Apr, Rajnish Wellness Ltd's stock price is rising, currently at 0.54, which reflects a change of 0.02 or 3.85% increase. This upward movement can be attributed to several factors. Over the past week, the stock has outperformed the benchmark Sensex, showing a remarkable increase of 20.00% compared to the Sensex's 5.77%. Additionally, in the last month, the stock has risen by 22.73%, while the Sensex has experienced a slight decline of 0.84%. <BR><BR>Today's performance indicates that the stock has outperformed its sector by 2.49%. Furthermore, the current price is higher than the 5-day, 20-day, and 50-day moving averages, suggesting a positive short-term trend. However, it is important to note that the stock's delivery volume has decreased by 29.23% compared to the 5-day average, indicating a potential decline in investor participation.<BR><BR>Despite these positive short-term movements, the company faces significant long-term challenges, including operating losses and a weak ability to service its debt, which may affect its future performance. The stock has generated a return of -42.55% over the past year, and the company has recorded a negative EBITDA of Rs. -2.03 crore. Therefore, while the stock is currently rising, it is essential to consider the underlying financial weaknesses that could impact its sustainability in the long run.

Which are the latest news on Rajnish Wellness?